|
gptkbp:instance_of
|
gptkb:biotechnology
|
|
gptkbp:acquisition
|
Acquired by Takeda Pharmaceutical Company
|
|
gptkbp:clinical_trial
|
ongoing
|
|
gptkbp:collaborations
|
biopharmaceutical companies
|
|
gptkbp:focus
|
drug discovery
|
|
gptkbp:founded
|
gptkb:2013
|
|
gptkbp:founder
|
gptkb:David_E._Shaw
|
|
gptkbp:headquarters
|
gptkb:New_York_City
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Envoy Therapeutics
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
|
gptkbp:investment
|
venture capital firms
|
|
gptkbp:key_people
|
gptkb:David_E._Shaw
gptkb:Robert_J._Mc_Cauley
gptkb:Michael_A._Marletta
|
|
gptkbp:location
|
gptkb:United_States
|
|
gptkbp:mission
|
improve patient outcomes
|
|
gptkbp:partnerships
|
academic institutions
|
|
gptkbp:products
|
therapeutics for neurological disorders
|
|
gptkbp:research_areas
|
drug development
|
|
gptkbp:specialization
|
neuroscience
|
|
gptkbp:technology
|
biologics
small molecules
|
|
gptkbp:type
|
private company
|
|
gptkbp:vision
|
transforming neuroscience
|
|
gptkbp:website
|
www.envoytherapeutics.com
|
|
gptkbp:bfsParent
|
gptkb:Takeda_Pharmaceutical_Company
gptkb:Takeda_Pharmaceuticals_International_AG
|
|
gptkbp:bfsLayer
|
5
|